Tag Archives: NASDAQ:ICLR
Icon plc (ICLR) Gets a Buy Rating from Credit Suisse
In a report issued on October 23, Erin Wright from Credit Suisse maintained a Buy rating on Icon plc (ICLR – Research Report), with a price target of $160.00. The company’s shares closed last Monday at $148.91. According to TipRanks.com,
Icon plc (ICLR) Receives a Hold from Barclays
Barclays analyst Jack Meehan maintained a Hold rating on Icon plc (ICLR – Research Report) yesterday and set a price target of $154. The company’s shares closed yesterday at $133.19. According to TipRanks.com, Meehan is a 4-star analyst with an
Analysts Offer Insights on Healthcare Companies: Icon plc (NASDAQ: ICLR) and Merck & Company (NYSE: MRK)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Icon plc (NASDAQ:ICLR) and Merck & Company (NYSE:MRK) with bullish sentiments. Icon plc (ICLR) Icon plc received a Buy rating and a
Credit Suisse Believes Icon plc (NASDAQ: ICLR) Won’t Stop Here
In a report issued on August 24, Erin Wright from Credit Suisse upgraded Icon plc (NASDAQ: ICLR) to Buy, with a price target of $159. The company’s shares closed on Friday at $144.49, close to its 52-week high of $149.69.
Icon plc Receives a Buy from Robert W. Baird
Robert W. Baird analyst Eric Coldwell reiterated a Buy rating on Icon plc (NASDAQ: ICLR) today and set a price target of $154. The company’s shares opened today at $144.86, close to its 52-week high of $146.31. According to TipRanks.com,
Icon plc Got Some Good News
In a report released yesterday, Erin Wright from Credit Suisse upgraded Icon plc (NASDAQ: ICLR) to Buy, with a price target of $131. The company’s shares closed yesterday at $113.86. According to TipRanks.com, Wright is a 5-star analyst with an
